Obesity and preclinical changes of cardiac geometry and function

scientific article

Obesity and preclinical changes of cardiac geometry and function is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.4070/KCJ.2010.40.2.55
P932PMC publication ID2827803
P698PubMed publication ID20182589
P5875ResearchGate publication ID41562800

P2093author name stringJang-Young Kim
Joong Kyung Sung
P2860cites workRimonabant for overweight or obesityQ24244078
Enhanced Sarcolemmal FAT/CD36 Content and Triacylglycerol Storage in Cardiac Myocytes From Obese Zucker RatsQ27832088
Functional consequences of caspase activation in cardiac myocytesQ28215640
Obesity and the risk of heart failureQ28216583
Apoptosis in the failing human heartQ73215232
Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat modelQ73492545
Myocardial substrate metabolism influences left ventricular energetics in vivoQ73630681
Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesityQ79362277
Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imagingQ79953401
Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) StudyQ80173759
Relation between epicardial adipose tissue and left ventricular massQ80846003
Adapted changes in left ventricular structure and function in severe uncomplicated obesityQ80984809
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic heartsQ81039999
Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight lossQ47343464
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophagesQ47735588
Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body massQ48484294
Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressureQ48621613
Alterations of left ventricular myocardial characteristics associated with obesity.Q51526288
Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat.Q52126699
Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins.Q53541654
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.Q54542487
Obesity and the Risk of New-Onset Atrial FibrillationQ57073134
Myocardial contractility and left ventricular function in obese patients with essential hypertensionQ58855539
Angiotensin II activates programmed myocyte cell death in vitroQ64389256
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac outputQ70367740
Obesity and left ventricular diastolic dysfunctionQ71258197
Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophyQ72351005
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart StudyQ72779135
Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G proteinQ28377109
Rat heart is a site of leptin production and actionQ28579489
Weight-reducing effects of the plasma protein encoded by the obese geneQ29617934
Prospective study of the association between sleep-disordered breathing and hypertensionQ29620492
Drug treatments for obesity: orlistat, sibutramine, and rimonabant.Q30359088
XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patientsQ33974818
Lipotoxic diseasesQ34111950
Obesity and hypertension: two epidemics or one?Q34311562
Absence of an effect of liposuction on insulin action and risk factors for coronary heart diseaseQ34327447
Effects of isolated obesity on systolic and diastolic left ventricular functionQ35581622
Diastolic dysfunction and left atrial volume: a population-based studyQ35998245
A look between the cardiomyocytes: the extracellular matrix in heart failureQ36378293
Lipotoxic heart disease in obese rats: implications for human obesityQ37117677
Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 yearsQ37323106
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.Q38321475
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in miceQ38352186
Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.Q38352512
Prevalence of obesity and metabolic syndrome in Korean adultsQ40156500
Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesityQ42021700
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in ratsQ42477638
Myocardial insulin-mediated glucose uptake and left ventricular geometryQ43594871
Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood InstituteQ43814939
Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.Q43935460
Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat.Q44021597
Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 miceQ44103922
Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db miceQ44286385
Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The framingham heart studyQ44415952
Obesity and cardiovascular risk factors in Korean children and adolescents aged 10-18 years from the Korean National Health and Nutrition Examination Survey, 1998 and 2001.Q44666173
The disease burden associated with overweight and obesityQ44817527
Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young womenQ44880994
Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization studyQ44957764
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.Q45032380
Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsQ45335905
Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbitQ46480671
Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axisQ46536950
Epicardial adipose tissue and insulin resistance in obese subjectsQ46642982
Adiponectin and left ventricular structure and function in healthy adultsQ46656838
Myocardial collagen turnover in normotensive obese patients: relation to insulin resistanceQ46664447
Randomized trial of lifestyle modification and pharmacotherapy for obesityQ46807914
Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 miceQ46818652
Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes.Q46866925
High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosisQ46935514
Body mass index is an independent determinant of left atrial sizeQ47284347
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectobesityQ12174
P304page(s)55-61
P577publication date2010-02-23
P1433published inKorean circulation journalQ26842331
P1476titleObesity and preclinical changes of cardiac geometry and function
P478volume40

Reverse relations

cites work (P2860)
Q37197090Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment
Q90648178Cardiac function in adolescents with obesity: cardiometabolic risk factors and impact on physical fitness
Q37525967High sodium intake in women with metabolic syndrome
Q48235896Impact of obstructive sleep apnea on the global myocardial performance beyond obesity